Clinical Trial Update: Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

This clinical trial update reports long-term safety and efficacy data for Efavaleukin Alfa in adults with moderately to severely active Ulcerative Colitis in a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Efavaleukin Alfa (efavaleukin alfa)

Snippet

Sponsor: Amgen | Conditions: Ulcerative Colitis | Phase 2 | Status: TERMINATED